UNIPHYLLIN

This brand name is authorized in Cyprus, Ireland, Malta, United Kingdom

Active ingredients

The drug UNIPHYLLIN contains one active pharmaceutical ingredient (API):

1 Theophylline
UNII C137DTR5RG - THEOPHYLLINE

Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output.

Read about Theophylline

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
UNIPHYLLIN CONTINUS Prolonged release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03DA04 Theophylline R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DA Xanthines
Discover more medicines within R03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 23279, 28920, 28926
Country: IE Health Products Regulatory Authority Identifier(s): 48747, 49026, 54852
Country: MT Medicines Authority Identifier(s): AA565/65501

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.